News & Events
RNA Mystery Solved in Triple Negative Breast Cancer
Researchers at Thomas Jefferson University have discovered why conventional efforts to block a tiny strand of ribonucleic acid, called microRNA, in triple negative breast cancer cells failed.
Jefferson Announces Opening of ALS Clinic and Affiliation with the ALS Association Greater Philadelphia Chapter
The Farber Institute for Neuroscience at Jefferson, in partnership with The ALS Association Greater Philadelphia Chapter, is pleased to announce that on January 8th, 2016, it will open the doors to a multidisciplinary ALS clinic.
Sidney Kimmel Medical College to Open Branch Campus with Atlantic Health System
Starting in July 2018, a group of students will have the opportunity to complete their third and fourth years of clinical training at the new SKMC/TJU-AHS Branch Campus.
Jefferson's Edith Mitchell makes EBONY Magazine's 2015 EBONY Power 100 List
EBONY Magazine announced that Edith Mitchell, M.D., Professor of Medical Oncology at Thomas Jefferson University and President of the National Medical Association, was named one of the individuals honored in the 2015 EBONY Power 100 List.
Sidney Kimmel Medical College at Thomas Jefferson University Selected to Join the American Medical Association’s Accelerating Change in Medical Education Consortium
SKMC was one of 20 medical schools chosen this year to join the 11 schools who were awarded grants in 2013, resulting in a 31 school consortium.
A Vaccine Candidate That Supports Immunity Where it Matters Most
Researchers at Thomas Jefferson University have found that one virus activates the immune system to continually feed sentinel cells into the mucous membranes where they could offer better and more immediate protection at the front lines, preventing disease before it occurs.
More Precise Due Dates for Pregnant Mothers
A new meta-analysis suggests that one routine screening test could help mothers narrow the due date window to seven days from the time of the test.
Building and Breaking Synapses
Researchers at Thomas Jefferson University have found a new way in which synapses organization is controlled, which could eventually lead to better treatments for neurological diseases.